Literature DB >> 12629328

The role of platelet receptors and adhesion molecules in coronary artery disease.

Waiel M Samara1, Paul A Gurbel.   

Abstract

Platelets play a significant role in coronary artery disease through interactions with each other and with other cell types. These interactions are mediated by certain receptors on the surface of platelets and other cells which can lead to intra-coronary thrombus formation and occlusion that may result in acute coronary syndromes. The important roles of the currently available anti-platelet therapies have been well established in many clinical outcome trials in cardiovascular patients. An understanding of these different interactions provides the clinician with a background that supports the clinical importance of currently available anti-platelet therapies. Moreover, knowledge of the mechanisms of cellular crosstalk will lead to important advances in the development of better antithrombotic therapies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629328     DOI: 10.1097/00019501-200302000-00008

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  4 in total

Review 1.  Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements.

Authors:  Joseph M Sweeny; Diana A Gorog; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

2.  The change of serum leptin and its relationship with platelet membrane glycoprotein Ib in patients with coronary heart disease.

Authors:  Dasheng Xia; Yanqiu Song; Chao Li; Feng Zhang; Minxin Wei
Journal:  Front Med China       Date:  2007-10

3.  Is a complete blood cell count useful in determining the prognosis of pulmonary embolism?

Authors:  Hadice Selimoglu Sen; Ozlem Abakay; Abdullah Cetin Tanrikulu; Cengizhan Sezgi; Mahsuk Taylan; Abdurrahman Abakay; Halide Kaya; Abdurrahman Senyigit
Journal:  Wien Klin Wochenschr       Date:  2014-03-25       Impact factor: 1.704

4.  Improving CHA2DS2-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation.

Authors:  Benjamin D Horne; Thomas Jared Bunch; Kevin G Graves; Heidi T May; Kirk U Knowlton; Joseph B Muhlestein; Victoria Jacobs; Donald L Lappé; Jeffrey L Anderson
Journal:  Open Heart       Date:  2018-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.